Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: JACC Heart Fail. 2013 Feb;1(1):40–47. doi: 10.1016/j.jchf.2012.08.001

Figure 3. Subgroup analysis for primary composite endpoint.

Figure 3

Association of new discharge prescriptions for aldosterone antagonists with primary composite endpoint of all-cause mortality or HF hospitalization in subgroups of propensity-matched older HF-PEF patients (EF=ejection fraction, GFR=glomerular filtration rate, HF=heart failure)

HHS Vulnerability Disclosure